Author: admin

Caris Assure™ detected clonal hematopoiesis (CH) mutations in ~40% of cases and demonstrated that CH identification and correction is vital for accurate therapy selection for cancer patients IRVING, Texas, Nov. 25, 2024 /PRNewswire/ — Caris Life Sciences® (Caris), a leading next-generation

Magazine made for you.

Featured:

No posts were found for provided query parameters.

Elsewhere: